Company Filing History:
Years Active: 1997-1998
Title: Suzanne L Bode: Innovator in Hepatitis C Research
Introduction
Suzanne L Bode is a prominent inventor based in Zion, IL (US). She has made significant contributions to the field of biotechnology, particularly in the development of diagnostic and therapeutic reagents for Hepatitis C.
Latest Patents
Suzanne holds 2 patents related to Hepatitis C virus fusion proteins and mammalian expression systems. Her latest patents include "Hepatitis C virus fusion proteins - Mammalian expression systems for the production of HCV fusion proteins," which provide high yields of HCV fusion proteins. This innovation enables the development of diagnostic and therapeutic reagents containing glycosylated structural antigens and allows for the isolation of the HCV etiological agent. Another patent, "Mammalian expression systems for HCV proteins," also focuses on high yields of HCV proteins, facilitating similar advancements in diagnostics and therapeutics.
Career Highlights
Suzanne is currently associated with Abbott Laboratories Corporation, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of Hepatitis C.
Collaborations
Some of her notable coworkers include James M Casey and Billy J Zeck, who have collaborated with her on various projects.
Conclusion
Suzanne L Bode's innovative work in the field of Hepatitis C research has made a significant impact on biotechnology. Her patents and contributions continue to pave the way for advancements in medical diagnostics and therapeutics.